UniProt ID | UIMC1_HUMAN | |
---|---|---|
UniProt AC | Q96RL1 | |
Protein Name | BRCA1-A complex subunit RAP80 | |
Gene Name | UIMC1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 719 | |
Subcellular Localization | Nucleus . Localizes at sites of DNA damage at double-strand breaks (DSBs). | |
Protein Description | Ubiquitin-binding protein. [PubMed: 24627472 Specifically recognizes and binds 'Lys-63'-linked ubiquitin] | |
Protein Sequence | MPRRKKKVKEVSESRNLEKKDVETTSSVSVKRKRRLEDAFIVISDSDGEEPKEENGLQKTKTKQSNRAKCLAKRKIAQMTEEEQFALALKMSEQEAREVNSQEEEEEELLRKAIAESLNSCRPSDASATRSRPLATGPSSQSHQEKTTDSGLTEGIWQLVPPSLFKGSHISQGNEAEEREEPWDHTEKTEEEPVSGSSGSWDQSSQPVFENVNVKSFDRCTGHSAEHTQCGKPQESTGRGSAFLKAVQGSGDTSRHCLPTLADAKGLQDTGGTVNYFWGIPFCPDGVDPNQYTKVILCQLEVYQKSLKMAQRQLLNKKGFGEPVLPRPPSLIQNECGQGEQASEKNECISEDMGDEDKEERQESRASDWHSKTKDFQESSIKSLKEKLLLEEEPTTSHGQSSQGIVEETSEEGNSVPASQSVAALTSKRSLVLMPESSAEEITVCPETQLSSSETFDLEREVSPGSRDILDGVRIIMADKEVGNKEDAEKEVAISTFSSSNQVSCPLCDQCFPPTKIERHAMYCNGLMEEDTVLTRRQKEAKTKSDSGTAAQTSLDIDKNEKCYLCKSLVPFREYQCHVDSCLQLAKADQGDGPEGSGRACSTVEGKWQQRLKNPKEKGHSEGRLLSFLEQSEHKTSDADIKSSETGAFRVPSPGMEEAGCSREMQSSFTRRDLNESPVKSFVSISEATDCLVDFKKQVTVQPGSRTRTKAGRGRRRKF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | Sumoylation | PRRKKKVKEVSESRN CCCHHHHHHHHHHCC | 62.37 | - | |
9 | Sumoylation | PRRKKKVKEVSESRN CCCHHHHHHHHHHCC | 62.37 | - | |
9 | Ubiquitination | PRRKKKVKEVSESRN CCCHHHHHHHHHHCC | 62.37 | 21906983 | |
9 (in isoform 1) | Ubiquitination | - | 62.37 | 21890473 | |
9 (in isoform 2) | Ubiquitination | - | 62.37 | 21890473 | |
9 (in isoform 5) | Ubiquitination | - | 62.37 | 21890473 | |
12 | Phosphorylation | KKKVKEVSESRNLEK HHHHHHHHHHCCCCC | 30.83 | 25159151 | |
19 | Ubiquitination | SESRNLEKKDVETTS HHHCCCCCCCCCCCC | 58.39 | - | |
20 | Sumoylation | ESRNLEKKDVETTSS HHCCCCCCCCCCCCC | 58.60 | - | |
20 | Sumoylation | ESRNLEKKDVETTSS HHCCCCCCCCCCCCC | 58.60 | 28112733 | |
20 | Ubiquitination | ESRNLEKKDVETTSS HHCCCCCCCCCCCCC | 58.60 | 21906983 | |
20 (in isoform 1) | Ubiquitination | - | 58.60 | 21890473 | |
20 (in isoform 2) | Ubiquitination | - | 58.60 | 21890473 | |
20 (in isoform 5) | Ubiquitination | - | 58.60 | 21890473 | |
24 | Phosphorylation | LEKKDVETTSSVSVK CCCCCCCCCCCCCCC | 31.65 | 28450419 | |
25 | Phosphorylation | EKKDVETTSSVSVKR CCCCCCCCCCCCCCC | 12.90 | 28450419 | |
26 | Phosphorylation | KKDVETTSSVSVKRK CCCCCCCCCCCCCCC | 35.84 | 28450419 | |
27 | Phosphorylation | KDVETTSSVSVKRKR CCCCCCCCCCCCCCC | 19.13 | 25159151 | |
29 | Phosphorylation | VETTSSVSVKRKRRL CCCCCCCCCCCCCCC | 24.70 | 23401153 | |
31 | Sumoylation | TTSSVSVKRKRRLED CCCCCCCCCCCCCCC | 44.70 | - | |
31 | Sumoylation | TTSSVSVKRKRRLED CCCCCCCCCCCCCCC | 44.70 | 28112733 | |
31 | Ubiquitination | TTSSVSVKRKRRLED CCCCCCCCCCCCCCC | 44.70 | 21890473 | |
31 (in isoform 1) | Ubiquitination | - | 44.70 | 21890473 | |
31 (in isoform 2) | Ubiquitination | - | 44.70 | 21890473 | |
31 (in isoform 5) | Ubiquitination | - | 44.70 | 21890473 | |
44 | Phosphorylation | EDAFIVISDSDGEEP CCCEEEEECCCCCCC | 21.84 | 25159151 | |
46 | Phosphorylation | AFIVISDSDGEEPKE CEEEEECCCCCCCCH | 40.50 | 23927012 | |
59 | Ubiquitination | KEENGLQKTKTKQSN CHHCCCCCCCCCHHH | 57.96 | - | |
75 | Sumoylation | AKCLAKRKIAQMTEE HHHHHHHHHHHCCHH | 41.51 | - | |
75 | Sumoylation | AKCLAKRKIAQMTEE HHHHHHHHHHHCCHH | 41.51 | 28112733 | |
75 | Ubiquitination | AKCLAKRKIAQMTEE HHHHHHHHHHHCCHH | 41.51 | 21906983 | |
75 (in isoform 1) | Ubiquitination | - | 41.51 | 21890473 | |
75 (in isoform 2) | Ubiquitination | - | 41.51 | 21890473 | |
75 (in isoform 5) | Ubiquitination | - | 41.51 | 21890473 | |
90 | Sumoylation | EQFALALKMSEQEAR HHHHHHHHHHHHHHH | 34.47 | - | |
90 | Sumoylation | EQFALALKMSEQEAR HHHHHHHHHHHHHHH | 34.47 | 28112733 | |
90 | Ubiquitination | EQFALALKMSEQEAR HHHHHHHHHHHHHHH | 34.47 | 906983 | |
90 (in isoform 1) | Ubiquitination | - | 34.47 | 21890473 | |
90 (in isoform 2) | Ubiquitination | - | 34.47 | 21890473 | |
90 (in isoform 5) | Ubiquitination | - | 34.47 | 21890473 | |
97 | Methylation | KMSEQEAREVNSQEE HHHHHHHHHHCCHHH | 47.87 | 115490305 | |
101 | Phosphorylation | QEAREVNSQEEEEEE HHHHHHCCHHHHHHH | 44.11 | 29255136 | |
110 (in isoform 4) | Ubiquitination | - | 6.29 | 21906983 | |
112 | Ubiquitination | EEEELLRKAIAESLN HHHHHHHHHHHHHHH | 44.08 | - | |
115 (in isoform 4) | Ubiquitination | - | 12.75 | 21906983 | |
124 | Phosphorylation | SLNSCRPSDASATRS HHHHCCCCCCCCCCC | 26.85 | 28555341 | |
127 | Phosphorylation | SCRPSDASATRSRPL HCCCCCCCCCCCCCC | 34.85 | 28555341 | |
129 | Phosphorylation | RPSDASATRSRPLAT CCCCCCCCCCCCCCC | 27.04 | 26714015 | |
131 | Phosphorylation | SDASATRSRPLATGP CCCCCCCCCCCCCCC | 33.62 | 28176443 | |
136 | Phosphorylation | TRSRPLATGPSSQSH CCCCCCCCCCCCCCC | 58.26 | 29116813 | |
137 (in isoform 3) | Ubiquitination | - | 17.93 | 21890473 | |
139 | Phosphorylation | RPLATGPSSQSHQEK CCCCCCCCCCCCCCC | 42.21 | 28176443 | |
140 | Phosphorylation | PLATGPSSQSHQEKT CCCCCCCCCCCCCCC | 38.54 | 23401153 | |
142 | Phosphorylation | ATGPSSQSHQEKTTD CCCCCCCCCCCCCCC | 29.14 | 28176443 | |
146 | Ubiquitination | SSQSHQEKTTDSGLT CCCCCCCCCCCCCCC | 50.59 | - | |
147 | Phosphorylation | SQSHQEKTTDSGLTE CCCCCCCCCCCCCCC | 34.77 | - | |
163 | Phosphorylation | IWQLVPPSLFKGSHI HHHCCCHHHHCCCCC | 40.13 | 24719451 | |
166 | Sumoylation | LVPPSLFKGSHISQG CCCHHHHCCCCCCCC | 65.87 | - | |
166 | Ubiquitination | LVPPSLFKGSHISQG CCCHHHHCCCCCCCC | 65.87 | - | |
167 (in isoform 3) | Ubiquitination | - | 19.68 | 21890473 | |
168 | Phosphorylation | PPSLFKGSHISQGNE CHHHHCCCCCCCCCC | 20.45 | 20363803 | |
171 | Phosphorylation | LFKGSHISQGNEAEE HHCCCCCCCCCCHHH | 26.98 | 29255136 | |
175 (in isoform 4) | Ubiquitination | - | 65.37 | 21906983 | |
188 | Sumoylation | EPWDHTEKTEEEPVS CCCCCCCCCCCCCCC | 63.49 | 28112733 | |
188 | Ubiquitination | EPWDHTEKTEEEPVS CCCCCCCCCCCCCCC | 63.49 | - | |
189 | Phosphorylation | PWDHTEKTEEEPVSG CCCCCCCCCCCCCCC | 42.25 | 23186163 | |
190 (in isoform 4) | Ubiquitination | - | 72.01 | 21906983 | |
195 | Phosphorylation | KTEEEPVSGSSGSWD CCCCCCCCCCCCCCC | 43.61 | 25159151 | |
197 | Phosphorylation | EEEPVSGSSGSWDQS CCCCCCCCCCCCCCC | 24.82 | 25159151 | |
198 | Phosphorylation | EEPVSGSSGSWDQSS CCCCCCCCCCCCCCC | 40.13 | 25159151 | |
200 | Phosphorylation | PVSGSSGSWDQSSQP CCCCCCCCCCCCCCC | 29.45 | 25159151 | |
204 | Phosphorylation | SSGSWDQSSQPVFEN CCCCCCCCCCCCEEC | 28.59 | 29116813 | |
205 | Phosphorylation | SGSWDQSSQPVFENV CCCCCCCCCCCEECC | 32.63 | 25159151 | |
215 | Ubiquitination | VFENVNVKSFDRCTG CEECCCCCCCCCCCC | 39.95 | 21906983 | |
215 (in isoform 1) | Ubiquitination | - | 39.95 | 21890473 | |
215 (in isoform 2) | Ubiquitination | - | 39.95 | 21890473 | |
218 (in isoform 4) | Ubiquitination | - | 52.41 | 21906983 | |
221 | Phosphorylation | VKSFDRCTGHSAEHT CCCCCCCCCCCCCCC | 38.53 | 28348404 | |
224 | Phosphorylation | FDRCTGHSAEHTQCG CCCCCCCCCCCCCCC | 36.38 | 27794612 | |
228 | Phosphorylation | TGHSAEHTQCGKPQE CCCCCCCCCCCCCCC | 19.63 | 27794612 | |
232 | Ubiquitination | AEHTQCGKPQESTGR CCCCCCCCCCCCCCC | 51.67 | - | |
236 | Phosphorylation | QCGKPQESTGRGSAF CCCCCCCCCCCCHHH | 30.80 | 25627689 | |
237 | Phosphorylation | CGKPQESTGRGSAFL CCCCCCCCCCCHHHH | 30.10 | 25627689 | |
239 | Methylation | KPQESTGRGSAFLKA CCCCCCCCCHHHHHH | 35.66 | 115490297 | |
241 | Phosphorylation | QESTGRGSAFLKAVQ CCCCCCCHHHHHHHC | 17.94 | 25159151 | |
245 | Sumoylation | GRGSAFLKAVQGSGD CCCHHHHHHHCCCCC | 39.81 | - | |
245 | Acetylation | GRGSAFLKAVQGSGD CCCHHHHHHHCCCCC | 39.81 | 26051181 | |
245 | Methylation | GRGSAFLKAVQGSGD CCCHHHHHHHCCCCC | 39.81 | 42366373 | |
245 | Sumoylation | GRGSAFLKAVQGSGD CCCHHHHHHHCCCCC | 39.81 | 28112733 | |
245 | Ubiquitination | GRGSAFLKAVQGSGD CCCHHHHHHHCCCCC | 39.81 | 21890473 | |
245 (in isoform 1) | Ubiquitination | - | 39.81 | 21890473 | |
250 | Phosphorylation | FLKAVQGSGDTSRHC HHHHHCCCCCCCCCH | 19.19 | 28450419 | |
253 | Phosphorylation | AVQGSGDTSRHCLPT HHCCCCCCCCCHHCC | 31.05 | 28450419 | |
254 | Phosphorylation | VQGSGDTSRHCLPTL HCCCCCCCCCHHCCH | 25.43 | 30576142 | |
260 | Phosphorylation | TSRHCLPTLADAKGL CCCCHHCCHHHCCCC | 22.94 | 26074081 | |
265 | Ubiquitination | LPTLADAKGLQDTGG HCCHHHCCCCCCCCC | 61.78 | - | |
273 (in isoform 4) | Ubiquitination | - | 13.61 | 21906983 | |
296 (in isoform 3) | Ubiquitination | - | 3.20 | 21890473 | |
304 (in isoform 3) | Ubiquitination | - | 33.75 | 21890473 | |
305 | Ubiquitination | CQLEVYQKSLKMAQR EHHHHHHHHHHHHHH | 39.82 | - | |
308 | Sumoylation | EVYQKSLKMAQRQLL HHHHHHHHHHHHHHH | 39.00 | - | |
308 | Sumoylation | EVYQKSLKMAQRQLL HHHHHHHHHHHHHHH | 39.00 | - | |
308 | Ubiquitination | EVYQKSLKMAQRQLL HHHHHHHHHHHHHHH | 39.00 | - | |
309 (in isoform 3) | Ubiquitination | - | 4.69 | 21890473 | |
314 (in isoform 2) | Ubiquitination | - | 6.57 | 21890473 | |
318 | Ubiquitination | QRQLLNKKGFGEPVL HHHHHCCCCCCCCCC | 59.40 | - | |
319 (in isoform 2) | Ubiquitination | - | 37.08 | 21890473 | |
330 | Phosphorylation | PVLPRPPSLIQNECG CCCCCCCHHHHCCCC | 40.56 | 29255136 | |
343 | Phosphorylation | CGQGEQASEKNECIS CCCCCCCHHHCCHHC | 49.12 | 29255136 | |
350 | Phosphorylation | SEKNECISEDMGDED HHHCCHHCCCCCCCC | 38.92 | 30108239 | |
350 (in isoform 3) | Ubiquitination | - | 38.92 | 21890473 | |
358 | Ubiquitination | EDMGDEDKEERQESR CCCCCCCHHHHHHHH | 60.47 | - | |
364 | Phosphorylation | DKEERQESRASDWHS CHHHHHHHHHHHHHH | 25.47 | 24719451 | |
372 | Ubiquitination | RASDWHSKTKDFQES HHHHHHHHCCCHHHH | 46.86 | - | |
374 | Ubiquitination | SDWHSKTKDFQESSI HHHHHHCCCHHHHHH | 61.35 | 21906983 | |
374 (in isoform 1) | Ubiquitination | - | 61.35 | 21890473 | |
378 (in isoform 2) | Ubiquitination | - | 46.58 | 21890473 | |
379 | Phosphorylation | KTKDFQESSIKSLKE HCCCHHHHHHHHHHH | 26.95 | 27732954 | |
380 | Phosphorylation | TKDFQESSIKSLKEK CCCHHHHHHHHHHHH | 33.03 | 20068231 | |
382 | Sumoylation | DFQESSIKSLKEKLL CHHHHHHHHHHHHHH | 52.24 | - | |
382 | Sumoylation | DFQESSIKSLKEKLL CHHHHHHHHHHHHHH | 52.24 | 28112733 | |
382 | Ubiquitination | DFQESSIKSLKEKLL CHHHHHHHHHHHHHH | 52.24 | 21890473 | |
382 (in isoform 1) | Ubiquitination | - | 52.24 | 21890473 | |
383 | Phosphorylation | FQESSIKSLKEKLLL HHHHHHHHHHHHHHC | 42.90 | 20068231 | |
387 | Sumoylation | SIKSLKEKLLLEEEP HHHHHHHHHHCCCCC | 42.73 | 28112733 | |
387 | Ubiquitination | SIKSLKEKLLLEEEP HHHHHHHHHHCCCCC | 42.73 | 21906983 | |
387 (in isoform 1) | Ubiquitination | - | 42.73 | 21890473 | |
393 (in isoform 2) | Ubiquitination | - | 38.27 | 21890473 | |
395 | Phosphorylation | LLLEEEPTTSHGQSS HHCCCCCCCCCCCCC | 44.18 | 30576142 | |
396 | Phosphorylation | LLEEEPTTSHGQSSQ HCCCCCCCCCCCCCC | 29.46 | 17525332 | |
397 | Phosphorylation | LEEEPTTSHGQSSQG CCCCCCCCCCCCCCC | 28.26 | 28450419 | |
401 | Phosphorylation | PTTSHGQSSQGIVEE CCCCCCCCCCCCEEE | 29.26 | 30576142 | |
402 | Phosphorylation | TTSHGQSSQGIVEET CCCCCCCCCCCEEEE | 25.25 | 17525332 | |
402 (in isoform 3) | Ubiquitination | - | 25.25 | 21890473 | |
407 (in isoform 3) | Ubiquitination | - | 54.35 | 21890473 | |
409 | Phosphorylation | SQGIVEETSEEGNSV CCCCEEEECCCCCCC | 28.12 | 28450419 | |
410 | Phosphorylation | QGIVEETSEEGNSVP CCCEEEECCCCCCCC | 36.61 | 28450419 | |
415 | Phosphorylation | ETSEEGNSVPASQSV EECCCCCCCCHHHHH | 40.09 | 17525332 | |
419 | Phosphorylation | EGNSVPASQSVAALT CCCCCCHHHHHHHHH | 19.54 | 17525332 | |
421 | Phosphorylation | NSVPASQSVAALTSK CCCCHHHHHHHHHCC | 15.95 | 23312004 | |
421 (in isoform 2) | Ubiquitination | - | 15.95 | 21890473 | |
426 | Phosphorylation | SQSVAALTSKRSLVL HHHHHHHHCCCEEEE | 27.72 | 27251275 | |
427 | Phosphorylation | QSVAALTSKRSLVLM HHHHHHHCCCEEEEC | 27.24 | 27251275 | |
428 | Acetylation | SVAALTSKRSLVLMP HHHHHHCCCEEEECC | 40.55 | 26051181 | |
428 | Sumoylation | SVAALTSKRSLVLMP HHHHHHCCCEEEECC | 40.55 | 28112733 | |
428 | Ubiquitination | SVAALTSKRSLVLMP HHHHHHCCCEEEECC | 40.55 | 21906983 | |
428 (in isoform 1) | Ubiquitination | - | 40.55 | 21890473 | |
430 | Phosphorylation | AALTSKRSLVLMPES HHHHCCCEEEECCCC | 26.94 | 25627689 | |
443 | Phosphorylation | ESSAEEITVCPETQL CCCCCEEEECCCCCC | 21.23 | 28348404 | |
448 | Phosphorylation | EITVCPETQLSSSET EEEECCCCCCCCCCC | 21.69 | 28348404 | |
451 | Phosphorylation | VCPETQLSSSETFDL ECCCCCCCCCCCEEC | 23.23 | 28348404 | |
452 | Phosphorylation | CPETQLSSSETFDLE CCCCCCCCCCCEECC | 40.56 | 28102081 | |
453 | Phosphorylation | PETQLSSSETFDLER CCCCCCCCCCEECCC | 36.96 | 28102081 | |
455 | Phosphorylation | TQLSSSETFDLEREV CCCCCCCCEECCCCC | 25.13 | 28102081 | |
463 | Phosphorylation | FDLEREVSPGSRDIL EECCCCCCCCCCHHH | 20.84 | 25159151 | |
466 | Phosphorylation | EREVSPGSRDILDGV CCCCCCCCCHHHHHE | 30.11 | 30266825 | |
466 (in isoform 3) | Ubiquitination | - | 30.11 | 21890473 | |
476 (in isoform 2) | Ubiquitination | - | 0.99 | 21890473 | |
480 | Sumoylation | VRIIMADKEVGNKED EEEEECCCCCCCHHH | 44.77 | - | |
480 | Sumoylation | VRIIMADKEVGNKED EEEEECCCCCCCHHH | 44.77 | - | |
480 | Ubiquitination | VRIIMADKEVGNKED EEEEECCCCCCCHHH | 44.77 | 21906983 | |
480 (in isoform 1) | Ubiquitination | - | 44.77 | 21890473 | |
481 (in isoform 3) | Ubiquitination | - | 57.09 | 21890473 | |
485 | Sumoylation | ADKEVGNKEDAEKEV CCCCCCCHHHHHHHH | 51.55 | - | |
485 | Sumoylation | ADKEVGNKEDAEKEV CCCCCCCHHHHHHHH | 51.55 | - | |
485 | Ubiquitination | ADKEVGNKEDAEKEV CCCCCCCHHHHHHHH | 51.55 | 21906983 | |
485 (in isoform 1) | Ubiquitination | - | 51.55 | 21890473 | |
498 | Phosphorylation | EVAISTFSSSNQVSC HHHHEECCCCCCEEC | 32.71 | - | |
509 (in isoform 3) | Ubiquitination | - | 56.84 | 21890473 | |
544 | Sumoylation | RQKEAKTKSDSGTAA HHHHCCCCCCCCCCC | 52.11 | - | |
544 | Sumoylation | RQKEAKTKSDSGTAA HHHHCCCCCCCCCCC | 52.11 | 28112733 | |
544 | Ubiquitination | RQKEAKTKSDSGTAA HHHHCCCCCCCCCCC | 52.11 | 21906983 | |
544 (in isoform 1) | Ubiquitination | - | 52.11 | 21890473 | |
545 | Phosphorylation | QKEAKTKSDSGTAAQ HHHCCCCCCCCCCCC | 42.09 | 30576142 | |
547 | Phosphorylation | EAKTKSDSGTAAQTS HCCCCCCCCCCCCCE | 45.17 | 30576142 | |
549 | Phosphorylation | KTKSDSGTAAQTSLD CCCCCCCCCCCCEEC | 23.83 | 28555341 | |
553 | Phosphorylation | DSGTAAQTSLDIDKN CCCCCCCCEECCCCC | 26.91 | 23312004 | |
554 | Phosphorylation | SGTAAQTSLDIDKNE CCCCCCCEECCCCCC | 16.38 | 25159151 | |
559 | Sumoylation | QTSLDIDKNEKCYLC CCEECCCCCCCEEEE | 68.30 | - | |
559 | Sumoylation | QTSLDIDKNEKCYLC CCEECCCCCCCEEEE | 68.30 | 28112733 | |
559 | Ubiquitination | QTSLDIDKNEKCYLC CCEECCCCCCCEEEE | 68.30 | 21906983 | |
559 (in isoform 1) | Ubiquitination | - | 68.30 | 21890473 | |
562 | Sumoylation | LDIDKNEKCYLCKSL ECCCCCCCEEEECCC | 37.26 | - | |
562 | Sumoylation | LDIDKNEKCYLCKSL ECCCCCCCEEEECCC | 37.26 | 25218447 | |
562 | Ubiquitination | LDIDKNEKCYLCKSL ECCCCCCCEEEECCC | 37.26 | - | |
564 (in isoform 3) | Ubiquitination | - | 26.63 | 21890473 | |
567 | Ubiquitination | NEKCYLCKSLVPFRE CCCEEEECCCCCCCE | 44.20 | - | |
575 | Phosphorylation | SLVPFREYQCHVDSC CCCCCCEEEEEHHHH | 16.51 | 25690035 | |
581 | Phosphorylation | EYQCHVDSCLQLAKA EEEEEHHHHHHHHHH | 18.68 | 25690035 | |
587 | Sumoylation | DSCLQLAKADQGDGP HHHHHHHHHHCCCCC | 62.17 | - | |
587 | Sumoylation | DSCLQLAKADQGDGP HHHHHHHHHHCCCCC | 62.17 | 28112733 | |
587 | Ubiquitination | DSCLQLAKADQGDGP HHHHHHHHHHCCCCC | 62.17 | 21906983 | |
587 (in isoform 1) | Ubiquitination | - | 62.17 | 21890473 | |
597 | Phosphorylation | QGDGPEGSGRACSTV CCCCCCCCCCCCCCC | 24.36 | 30576142 | |
602 | Phosphorylation | EGSGRACSTVEGKWQ CCCCCCCCCCCCHHH | 34.21 | 23312004 | |
603 | Phosphorylation | GSGRACSTVEGKWQQ CCCCCCCCCCCHHHH | 23.59 | 30576142 | |
607 | Sumoylation | ACSTVEGKWQQRLKN CCCCCCCHHHHHHCC | 28.46 | - | |
607 | Acetylation | ACSTVEGKWQQRLKN CCCCCCCHHHHHHCC | 28.46 | 26051181 | |
607 | Sumoylation | ACSTVEGKWQQRLKN CCCCCCCHHHHHHCC | 28.46 | 28112733 | |
607 | Ubiquitination | ACSTVEGKWQQRLKN CCCCCCCHHHHHHCC | 28.46 | - | |
618 | Ubiquitination | RLKNPKEKGHSEGRL HHCCHHHCCCCHHHH | 68.96 | - | |
627 | Phosphorylation | HSEGRLLSFLEQSEH CCHHHHHHHHHHCCC | 32.17 | 25159151 | |
632 | Phosphorylation | LLSFLEQSEHKTSDA HHHHHHHCCCCCCCC | 32.09 | 23312004 | |
635 | Sumoylation | FLEQSEHKTSDADIK HHHHCCCCCCCCCCC | 45.75 | - | |
635 | Sumoylation | FLEQSEHKTSDADIK HHHHCCCCCCCCCCC | 45.75 | 28112733 | |
635 | Ubiquitination | FLEQSEHKTSDADIK HHHHCCCCCCCCCCC | 45.75 | - | |
636 | Phosphorylation | LEQSEHKTSDADIKS HHHCCCCCCCCCCCC | 33.47 | 28509920 | |
637 | Phosphorylation | EQSEHKTSDADIKSS HHCCCCCCCCCCCCC | 35.29 | 28509920 | |
642 | Sumoylation | KTSDADIKSSETGAF CCCCCCCCCCCCCCE | 48.77 | 28112733 | |
642 | Ubiquitination | KTSDADIKSSETGAF CCCCCCCCCCCCCCE | 48.77 | 2190698 | |
642 (in isoform 1) | Ubiquitination | - | 48.77 | 21890473 | |
643 | Phosphorylation | TSDADIKSSETGAFR CCCCCCCCCCCCCEE | 33.47 | 23403867 | |
644 | Phosphorylation | SDADIKSSETGAFRV CCCCCCCCCCCCEEC | 33.89 | 28464451 | |
646 | Phosphorylation | ADIKSSETGAFRVPS CCCCCCCCCCEECCC | 35.44 | 23403867 | |
653 | Phosphorylation | TGAFRVPSPGMEEAG CCCEECCCCCCHHHC | 31.09 | 19664994 | |
656 | Sulfoxidation | FRVPSPGMEEAGCSR EECCCCCCHHHCCCH | 4.83 | 21406390 | |
661 | Carbamidation | PGMEEAGCSREMQSS CCCHHHCCCHHHHHH | 4.46 | 17322306 | |
662 | Phosphorylation | GMEEAGCSREMQSSF CCHHHCCCHHHHHHC | 30.29 | 23927012 | |
667 | Phosphorylation | GCSREMQSSFTRRDL CCCHHHHHHCCCCCC | 26.55 | 26074081 | |
668 | Phosphorylation | CSREMQSSFTRRDLN CCHHHHHHCCCCCCC | 17.47 | 23401153 | |
670 | Phosphorylation | REMQSSFTRRDLNES HHHHHHCCCCCCCCC | 27.09 | 26074081 | |
677 | Phosphorylation | TRRDLNESPVKSFVS CCCCCCCCCCCEEEE | 33.64 | 29255136 | |
680 | Acetylation | DLNESPVKSFVSISE CCCCCCCCEEEEHHH | 41.37 | 7681407 | |
681 | Phosphorylation | LNESPVKSFVSISEA CCCCCCCEEEEHHHH | 30.99 | 23927012 | |
684 | Phosphorylation | SPVKSFVSISEATDC CCCCEEEEHHHHHCC | 20.56 | 28464451 | |
686 | Phosphorylation | VKSFVSISEATDCLV CCEEEEHHHHHCCEE | 17.42 | 24732914 | |
689 | Phosphorylation | FVSISEATDCLVDFK EEEHHHHHCCEEEEC | 24.16 | 24732914 | |
696 | Acetylation | TDCLVDFKKQVTVQP HCCEEEECCCEEECC | 37.52 | 24468251 | |
696 | Sumoylation | TDCLVDFKKQVTVQP HCCEEEECCCEEECC | 37.52 | 28112733 | |
696 | Ubiquitination | TDCLVDFKKQVTVQP HCCEEEECCCEEECC | 37.52 | - | |
697 | Sumoylation | DCLVDFKKQVTVQPG CCEEEECCCEEECCC | 50.42 | 28112733 | |
697 | Ubiquitination | DCLVDFKKQVTVQPG CCEEEECCCEEECCC | 50.42 | - | |
700 | Phosphorylation | VDFKKQVTVQPGSRT EEECCCEEECCCCCC | 15.78 | - | |
705 | Phosphorylation | QVTVQPGSRTRTKAG CEEECCCCCCCCCCC | 36.84 | 28985074 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
44 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
46 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
205 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
205 | S | Phosphorylation | Kinase | ATR | Q13535 | PSP |
402 | S | Phosphorylation | Kinase | ATM | Q13315 | GPS |
627 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
677 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UIMC1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UIMC1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44; SER-46; SER-627;SER-653 AND SER-677, AND MASS SPECTROMETRY. | |
"RAP80 responds to DNA damage induced by both ionizing radiation andUV irradiation and is phosphorylated at Ser 205."; Yan J., Yang X.-P., Kim Y.-S., Jetten A.M.; Cancer Res. 68:4269-4276(2008). Cited for: PHOSPHORYLATION AT SER-205, AND MUTAGENESIS OF SER-205. | |
"Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damageresponse."; Kim H., Chen J., Yu X.; Science 316:1202-1205(2007). Cited for: FUNCTION, IDENTIFICATION IN THE BRCA1-A COMPLEX, SUBCELLULAR LOCATION,UBIQUITIN-BINDING, PHOSPHORYLATION AT SER-101, AND MUTAGENESIS OFALA-88; SER-92; ALA-113 AND SER-117. | |
"RAP80 targets BRCA1 to specific ubiquitin structures at DNA damagesites."; Sobhian B., Shao G., Lilli D.R., Culhane A.C., Moreau L.A., Xia B.,Livingston D.M., Greenberg R.A.; Science 316:1198-1202(2007). Cited for: FUNCTION, IDENTIFICATION IN THE BRCA1-A COMPLEX, SUBCELLULAR LOCATION,UBIQUITIN-BINDING, AND PHOSPHORYLATION AT SER-101. | |
"Abraxas and RAP80 form a BRCA1 protein complex required for the DNAdamage response."; Wang B., Matsuoka S., Ballif B.A., Zhang D., Smogorzewska A., Giyi S.,Elledge S.J.; Science 316:1194-1198(2007). Cited for: FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-140; SER-402AND SER-419, AND MUTAGENESIS OF ALA-88; SER-92; ALA-113 AND SER-117. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140; SER-402; SER-415AND SER-419, AND MASS SPECTROMETRY. | |
"The ubiquitin-interacting motif containing protein RAP80 interactswith BRCA1 and functions in DNA damage repair response."; Yan J., Kim Y.S., Yang X.-P., Li L.-P., Liao G., Xia F., Jetten A.M.; Cancer Res. 67:6647-6656(2007). Cited for: FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF ALA-88 AND ALA-113, ANDPHOSPHORYLATION AT SER-205 AND SER-402. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44 AND SER-46, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-597; SER-653 ANDSER-677, AND MASS SPECTROMETRY. |